Home » Topics » BioWorld Science

BioWorld Science
RSS

Cholestyramine treatment of peri-anal irritation in an infant

Oct. 25, 1996

Glaxo Wellcome to develop Glylorin

Oct. 25, 1996

Absorbent wound dressing cleared for launch in the U.S.

Oct. 25, 1996

Successful completion of Dermagraft pivotal trial

Oct. 25, 1996

VEGF-B, potential angiogenesis stimulant

Oct. 25, 1996

Glaxo Wellcome anesthetic receives European clearance

Oct. 25, 1996

Novel antimigraine agent launched in the U.K.

Oct. 25, 1996

Antimigraine agents with affinity for 5-HT receptors reported by Pierre Fabre

Oct. 25, 1996

Anesta's Actiq on schedule for launch

Oct. 25, 1996

Neurex broadens clinical program for SNX-111

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...